Long-term therapeutic effects of Katona therapy in moderate-to-severe perinatal brain damage

Manuel Hinojosa-Rodríguez1, José Oliver De Leo- Jiménez1, María Elena Juárez- Colín1

  • 1Unidad de Investigación en Neurodesarrollo, Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus Juriquilla, México.

Neuroscience Letters
|September 4, 2020
PubMed

Insights

Katona therapy significantly improves motor function in infants with perinatal brain damage (PBD). Early rehabilitation reduces long-term motor disability, showing lasting therapeutic effects.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Rehabilitation Medicine

Background:

  • Perinatal brain damage (PBD) can lead to significant long-term motor disabilities in infants.
  • Early intervention is crucial for managing the effects of PBD.
  • The efficacy of long-term rehabilitation strategies requires further investigation.

Purpose of the Study:

  • To evaluate the long-term effectiveness of Katona therapy and early rehabilitation in infants diagnosed with moderate-to-severe PBD.
  • To compare motor outcomes between infants treated early with Katona therapy and those with delayed or no early intervention.
  • To assess the impact of Katona therapy on neurological function and brain structure.

Main Methods:

  • A cohort of 32 participants (7-16 years) was divided into a healthy group, a PBD group treated with Katona therapy from 2 months corrected age, and a PBD group with late diagnosis and no early treatment.
  • Neuropediatric evaluations, motor evoked potentials (MEPs), and magnetic resonance imaging (MRI) were conducted.
  • K-means cluster analysis was applied to MRI, MEPs, and clinical data.

Main Results:

  • Infants treated with Katona therapy demonstrated superior motor function compared to the untreated PBD group, with 75% in levels I-II vs. 78% in levels III-IV.
  • While MRI results showed similar clustering between PBD groups, MEPs and neuropediatric evaluations indicated that 67% of the Katona-treated group clustered with the healthy group.
  • These findings suggest a significant positive impact of Katona therapy on functional recovery.

Conclusions:

  • Katona therapy and early rehabilitation provide substantial therapeutic benefits for infants with moderate-to-severe PBD.
  • Early intervention through Katona therapy effectively decreases the severity of motor disability in later life stages.
  • The study underscores the importance of timely and targeted rehabilitation for improving outcomes in pediatric neurological conditions.
Abstract